CN109609560A - Method for biosynthesizing 3,4-dihydroxyphenylacetic acid - Google Patents
Method for biosynthesizing 3,4-dihydroxyphenylacetic acid Download PDFInfo
- Publication number
- CN109609560A CN109609560A CN201811600449.6A CN201811600449A CN109609560A CN 109609560 A CN109609560 A CN 109609560A CN 201811600449 A CN201811600449 A CN 201811600449A CN 109609560 A CN109609560 A CN 109609560A
- Authority
- CN
- China
- Prior art keywords
- dhpa
- hpabc
- acid
- bacterium
- host
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CFFZDZCDUFSOFZ-UHFFFAOYSA-N 3,4-Dihydroxy-phenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C(O)=C1 CFFZDZCDUFSOFZ-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims abstract description 19
- 230000003570 biosynthesizing effect Effects 0.000 title abstract 2
- XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 23
- 108010019831 4-hydroxyphenylacetate 3-monooxygenase Proteins 0.000 claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 claims abstract description 10
- 241000894006 Bacteria Species 0.000 claims description 22
- 241000233866 Fungi Species 0.000 claims description 16
- 230000015572 biosynthetic process Effects 0.000 claims description 15
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 241000196324 Embryophyta Species 0.000 claims description 8
- 108091000080 Phosphotransferase Proteins 0.000 claims description 6
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims description 6
- 102000020233 phosphotransferase Human genes 0.000 claims description 6
- 230000009466 transformation Effects 0.000 claims description 6
- 229960003424 phenylacetic acid Drugs 0.000 claims description 5
- 239000003279 phenylacetic acid Substances 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 108010074633 Mixed Function Oxygenases Proteins 0.000 claims description 4
- 102000008109 Mixed Function Oxygenases Human genes 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 238000006555 catalytic reaction Methods 0.000 claims description 3
- QXGJCWSBOZXWOV-UHFFFAOYSA-N 3,4-dihydroxyphthalic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1C(O)=O QXGJCWSBOZXWOV-UHFFFAOYSA-N 0.000 abstract description 43
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 29
- 230000033228 biological regulation Effects 0.000 abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 9
- 239000008103 glucose Substances 0.000 abstract description 9
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 5
- 230000037353 metabolic pathway Effects 0.000 abstract description 3
- 238000012269 metabolic engineering Methods 0.000 abstract description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 229910052799 carbon Inorganic materials 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 238000005755 formation reaction Methods 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 230000005611 electricity Effects 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 229940076788 pyruvate Drugs 0.000 description 5
- 108010055471 Phenylacetaldehyde dehydrogenase Proteins 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- 108010065394 aminopherase Proteins 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 230000008676 import Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 150000004715 keto acids Chemical class 0.000 description 3
- 150000007965 phenolic acids Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 3
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical class OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000014701 Transketolase Human genes 0.000 description 2
- 108010043652 Transketolase Proteins 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 108010062110 water dikinase pyruvate Proteins 0.000 description 2
- WTFXTQVDAKGDEY-UHFFFAOYSA-N (-)-chorismic acid Natural products OC1C=CC(C(O)=O)=CC1OC(=C)C(O)=O WTFXTQVDAKGDEY-UHFFFAOYSA-N 0.000 description 1
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- IUUBODMNDCMSEU-UHFFFAOYSA-N 3-[6-amino-3-(3-hydroxypropyl)-2,4,5,9-tetrahydropurin-2-yl]propan-1-ol Chemical compound NC1=NC(CCCO)N(CCCO)C2N=CNC12 IUUBODMNDCMSEU-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 241001522296 Erithacus rubecula Species 0.000 description 1
- 241001013691 Escherichia coli BW25113 Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000016761 Haem oxygenases Human genes 0.000 description 1
- 108050006318 Haem oxygenases Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 229930189396 Mycinamycin Natural products 0.000 description 1
- 108010035004 Prephenate Dehydrogenase Proteins 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TXAHPQBGJGJQME-UHFFFAOYSA-N acetaldehyde;phenol Chemical compound CC=O.OC1=CC=CC=C1 TXAHPQBGJGJQME-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical class OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- WTFXTQVDAKGDEY-HTQZYQBOSA-N chorismic acid Chemical compound O[C@@H]1C=CC(C(O)=O)=C[C@H]1OC(=C)C(O)=O WTFXTQVDAKGDEY-HTQZYQBOSA-N 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical class COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000000640 hydroxylating effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 101150044508 key gene Proteins 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- FPWMCUPFBRFMLH-HDKIZWTHSA-N prephenic acid Chemical compound O[C@H]1C=C[C@](CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-HDKIZWTHSA-N 0.000 description 1
- FPWMCUPFBRFMLH-UHFFFAOYSA-N prephenic acid Natural products OC1C=CC(CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-UHFFFAOYSA-N 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- REFJWTPEDVJJIY-UHFFFAOYSA-N quercetin Natural products C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- -1 quercetin glycoside Chemical class 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
生物合成3、4‑二羟基苯乙酸的方法涉及生物技术和代谢工程领域。本发明公开了生物合成3,4‑DHPA的途径，宿主及其方法。在所述产3,4‑DHPA的宿主中导入了3,4‑DHPA生产的代谢途径。更确切的说，是在宿主中高效表达了4‑羟基苯乙酸羟化酶(HpaBC)来生物转化4‑羟基苯乙酸为3,4‑DHPA。将所编码的基因导入宿主中，结果得到了可以利用4‑羟基苯乙酸、葡萄糖，甘油等生产3,4‑DHPA的宿主。同时本发明还公开了一种基因调控的策略，使得3,4‑DHPA的生产更为高效。
The method for biosynthesizing 3,4-dihydroxyphenylacetic acid relates to the fields of biotechnology and metabolic engineering. The invention discloses a biosynthetic pathway, host and method of 3,4-DHPA. A metabolic pathway for 3,4-DHPA production is introduced into the 3,4-DHPA-producing host. More precisely, 4-hydroxyphenylacetic acid hydroxylase (HpaBC) is highly expressed in the host to bioconvert 4-hydroxyphenylacetic acid to 3,4-DHPA. The encoded gene is introduced into the host, and as a result, a host that can utilize 4-hydroxyphenylacetic acid, glucose, glycerol, etc. to produce 3,4-DHPA is obtained. At the same time, the invention also discloses a gene regulation strategy, which makes the production of 3,4-DHPA more efficient.
Description
Technical field
The present invention relates to biotechnologys and metabolic engineering field, more precisely, the present invention relates to heterologous organisms synthesis 3,
The method of the metabolic pathway and gene regulation of 4- dihydroxyphenyl acetic acid (3,4-DHPA), selection derive from bacterium, fungi or albumen
The engineered exogenous enzymes of matter select bacterium original or being transformed, and fungi, plant cell or zooblast are thin as host
Born of the same parents, and by RED recombination edit carry out gene regulation, finally improve 3,4- dihydroxyphenyl acetic acid yield and
Carbon source yield.
Background technique
Phenolic acid because its is anti-oxidant, antibacterial and other biological activities and be widely used in food, cosmetics and pharmaceuticals industry.3,4-
Dihydroxyphenyl acetic acid is naturally occurring phenolic acid, shows powerful free radical scavenging activity.It can reduce lipid peroxy
Change, and natural can be used potentially as to replace butylated hydroxytoluene (BHT) and butylated hydroxyanisol
(BHA) with stable edible oil.3,4-DHPA also shows several activity beneficial to health.It is quercetin glycoside in diet
One of with phenolic acid the most abundant in the primary bioactivity catabolite of flavonoids and fruits and vegetables, and to cell
Apoptosis, mitochondria dysfunction and oxidative stress etc. have protective effect, can induce cystine transhipment enzyme, Glutathione Transport
The expression of enzyme, heme oxygenase, cytochromes enzyme etc..In prostate cancer and colon cancer cell, 3,4-DHPA are also showed
Strong antiproliferative activity out.In addition, proinflammatory thin in 3, the 4-DHPA peripheral blood mononuclear cells that lipopolysaccharides can also be inhibited to stimulate
The expression of p-selectin in the secretion of intracellular cytokine and resting platelets.
Although 3, the 4-DHPA significant health benefits having, economical and environmentally friendly 3,4-DHPA are also lacked so far
Production method.Therefore, it is necessary to effective synthetic strategy be established, to provide 3, the 4-DHPA compound of sufficient amount for visiting
Rope and apply its multiple functions.3,4-DHPA is extracted by low-purity, poor efficiency, high-cost limitation from natural origin.For
Chemical synthesis, regioselectivity neighbour's hydroxylating on phenyl ring are challenging always, and chemical synthesis also will be in face of height
Pollution, low yield, Gao Chengben, the problems such as time-consuming.Previous studies produce 3 using the electrochemical conversion of phenylacetic acid (PAA),
4-DHPA, but the mixture of dihydroxy PAA is formd, make product be difficult to separate.Therefore, it is closed using green and efficient biology
Just become the best selection of production 3,4-DHPA at method.
Present invention is primarily aimed at efficiently synthesizing for the biological method for realizing 3,4-DHPA.Screened catalytic efficiency compared with
High 4-Hydroxyphenylacetate 3-monooxygenase HpaBC realizes the bioconversion from 4- hydroxyl phenylacetic acid to 3,4-DHPA.Equally
The new metabolic pathway of engineer realizes the de novo formation of 3,4-DHPA, and in addition the invention also discloses a kind of knockout places
Pure grape is respectively adopted in the gene regulation strategy of the gene PYKA and PYKF of encoding pyruvate acid kinase and one kind in key-gene group
Sugar, pure glycerin, glucose and glycerol are mixed into carbon source to realize the dynamic regulation strategy of yield and growth coordination.Experimental result table
Bright, under optimization of fermentation conditions, the bioconversion of 4- hydroxyl phenylacetic acid to 3,4-DHPA can reach 100% conversion ratio in 48h；
And the maximum carbon source receipts of the maximum production of 1856 ± 67 mg/L and 0.1741% can be reached by de novo formation, 3,4-DHPA
Rate.
Summary of the invention
The object of the present invention is to provide high yield 3, the host of 4-DHPA, by bacterium original or being transformed, fungi,
The approach for efficiently producing 3,4-DHPA is imported in plant cell or zooblast, selection derives from bacterium, fungi or albumen
The engineered 4-Hydroxyphenylacetate 3-monooxygenase HpaBC of matter realizes 3,4- by the high efficient expression of HpaBC in host
Biosynthesis of the DHPA from 4- hydroxyl phenylacetic acid.
A kind of biosynthesis 3,4- dihydroxyphenyl acetic acid method, it is characterised in that: under being 6-8 at 30-37 DEG C and pH, 4-
Hydroxyl phenylacetic acid 3- monooxygenase HpaBC is catalyzed 3 to 60 hours, and catalysis 4- hydroxyl phenylacetic acid is generated 3,4- dihydroxy benzenes second
Acid.
Screening derives from bacterium, fungi or the coding 4-Hydroxyphenylacetate 3-monooxygenase by protein engineering transformation
Gene HpaBC.3, the host of 4- dihydroxyphenyl acetic acid production ways includes bacterium, fungi, plant cell or zooblast,
Including the bacterium being transformed, fungi, plant cell or zooblast.
Gene PYKA, PYKF or PYKA of encoding pyruvate acid kinase in host genome and PYKF are knocked out, raising 3,
4- dihydroxyphenyl acetic acid yield.
The present invention also provides the methods that microorganism produces 3,4-DHPA: first method is external addition substrate 4- hydroxy benzenes
Acetic acid, to bacterium original or being transformed, fungi imports 4-Hydroxyphenylacetate 3-monooxygenase in plant cell or zooblast
HpaBC, and be building up on the carrier of middle copy and expressed.Then, this is produced into the host of 3,4-DHPA in LB Tube propagation base
In be incubated overnight, later transfer 1%-4% volume bacterium solution into the M9 culture medium for the 4- hydroxyl phenylacetic acid for being added to 3g/L,
37 DEG C of culture 48h.It is sampled after addition inducer every 12h and surveys OD, and measure the concentration of 3,4-DHPA with high performance liquid chromatography.The
Two kinds of methods are de novo formations, and to bacterium original or being transformed, it is de- to import prephenic acid in plant cell or zooblast for fungi
Hydrogen enzyme TyrA, phosphoenolpyruvate synthase PpsA, transketolase TktA, 3- deoxidation-D-arabinose-heptonic acid -7- phosphoric acid close
At enzyme AroG, aminopherase AT, keto acid decarboxylase ARO10, the mono- oxygenation of phenylacetaldehyde dehydrogenase FeaB, 4- hydroxyl phenylacetic acid 3-
Enzyme HpaBC, expressed in high copy number plasmid respectively expression HpaBC, TyrA in ARO10, FeaB and middle copy plasmid, PpsA,
TktA,AroG.Then at 37 DEG C, by this strain inoculated to glucose (glucose) or glycerol (glycerol) for carbon source
M9 culture medium in ferment, and sampled from fermentation liquid, using high performance liquid chromatography to 12h, for 24 hours, the hair of 36h, 48h
The concentration of zymotic fluid product is analyzed.
The present invention also provides microbe high-yield 3, the method for 4-DHPA specifically has following several: first is to optimize table
Up to module, HpaBC is optimized for middle copy from high copy expression and is expressed, makes upstream and downstream enzyme amount expression balance.Second is the introduction of
Gene regulation strategy, gene PYKA, the PYKF for having knocked out encoding pyruvate acid kinase reduce the generation of by-product, increase product
Formation.The dynamic regulation strategy that third is the introduction of yield and growth is coordinated selects to realize place with glucose for single carbon source
Main fast-growth selects the efficient production for realizing 3,4-DHPA for single carbon source with glycerol, and selection is with glucose and glycerol
The dynamic regulation of mixed carbon source (2:1) realization yield and growth.Finally, in vitro in addition experiment, in 48h, the 4- hydroxyl of 3g/L
Base phenylacetic acid is converted into 3,4-DHPA by 100%；In de novo formation, from the mixed carbon source of glycerol and glucose, 3,4-
DHPA can reach the maximum production of 1856 ± 67mg/L and 0.1714% carbon source yield；From glycerol, 3,4-DHPA
The yield of 1750 ± 73mg/L and 0.1741% maximum carbon source yield can be reached.
As described above, the present invention relates to effective production method of 3,4-DHPA and high yield host, the method and hosts
Be characterized by that screening activity is high and the enzyme of high efficient expression, construct biosynthesis 3, the artificial approach of 4-DHPA designs base
Because of the method for the dynamic regulation strategy that regulating strategy, yield and growth are coordinated, and optimize the culture medium in fermentation process and training
The condition of supporting, to realize efficiently synthesizing for 3,4-DHPA.
Detailed description of the invention
Fig. 1 de novo formation and addition experiment produce the path of 3,4-DHPA；
The bacterium that Fig. 2 imports the original of 4-Hydroxyphenylacetate 3-monooxygenase (HpaBC) gene or was transformed, fungi are planted
The fermentation results that object cell or zooblast bioconversion 4-HPA are 3,4-DHPA；
Fig. 3 imports aminopherase (AT), keto acid decarboxylase (ARO10), phenylacetaldehyde dehydrogenase (FeaB), 4- hydroxy benzenes
Acetic acid 3- monooxygenase (HpaBC), shikimic acid pathway TyrAfbr, PpsA, TktA and AroGfbrEnzyme gene original was transformed
Bacterium, fungi, plant cell or zooblast, from glucose, the glycerol head that sets out synthesizes the fermentation results of 3,4-DHPA；
Fig. 4 knocks out gene PYKA, PYKF or PYKA of encoding pyruvate acid kinase in host genome and PYKF respectively,
It effectively prevents after PEP is largely converted into pyruvic acid, from glucose, the glycerol head that sets out synthesizes the fermentation results of 3,4-DHPA；
Specific embodiment
Specific embodiment 1
3,4-DHPA is produced by adding 4- hydroxyl phenylacetic acid in vitro
Pass through the homologous modeling point of sequence alignment (https: //blast.ncbi.nlm.nih.gov) and Modeller software
Analysis, screening derive from the 4-Hydroxyphenylacetate 3-monooxygenase HpaBC of bacterium, fungi or protein engineering transformation.Wherein HpaBC
Transformation include F101A, S112G, A128N, E144T, P152Y.It is obtained from plasmid or microbial genome by round pcr
The genetic fragment for obtaining 4-Hydroxyphenylacetate 3-monooxygenase (HpaBC), then, using restriction endonuclease to genetic fragment
Digestion is carried out with plasmid vector, the segment after digestion is subjected to glue recycling or column and is recycled, is then added 4- hydroxyl phenylacetic acid 3- is mono-
Oxygenase (HpaBC) target gene is inserted on plasmid pCS27 (middle copy), acquisition pCS-HpaBC recombinant plasmid, and utilization PCR,
Digestion carries out plasmid verifying.
Using electric robin preparation Escherichia coli BW25113 (knocked out in original Escherichia coli lacZWJ16, hsdR514,
AraBADAH33, rhaBADLD78) competent cell, and draw 100 μ L had been built up in the EP pipe of 1.5 mL with 4 μ L
Plasmid pCS-HpaBC be sufficiently mixed, be placed on ice 10min pre-cooling.Then sufficient bacterium solution will be mixed and electricity is added in plasmid
It hits in cup, and is rotated into plasmid electricity into competent cell using electroporation.After the completion of electricity turns, 700 μ L LB culture mediums are added, mix
It closes uniformly, and mixture is transferred in 1.5mL centrifuge tube, the recovery 30min at 37 DEG C.It takes 100 μ L bacterium solutions to be coated onto later to contain
On the plate for having kanamycins antibiotic, 37 DEG C are incubated overnight.Bioconversion 4- hydroxyl phenylacetic acid is built into 3,4-DHPA's
Bacterial strain BW (pCS-HpaBC).
Three parallel single colonies of picking on the plate of bacterial strain BW (pCS-HpaBC) are connected to the mould with that is blocked of 4mL
In the liquid LB of plain resistance, 12h is cultivated at 37 DEG C, and the bacterium solution of 1mL in LB (2% volume ratio) is inoculated into having for 50mL later
(medium component includes 7g/L Na to the M9 culture medium of kalamycin resistance2HPO4, 3g/L KH2PO4, 0.5g/L NaCl, 1g/L
NH4Cl, 2.5g/L glucose, 5g/L yeast powder in 2g/L 3- N-morpholinyl (MOPS), and directly add final concentration of
Inducer IPTG is added after then cultivating 3 hours, 3 hours in 37 DEG C, the shaking table of 200r/min in the 4- hydroxyl phenylacetic acid of 3g/L
It is induced, concentration 1mM.It is sampled when 12 hours, 24 hours, 36 hours and 48 hours respectively later, use is ultraviolet
Its growing state of spectrophotometric determination, and the concentration of 3,4-DHPA and the consumption feelings of substrate are measured with high performance liquid chromatography
Condition.It is tested by addition, be that 4- hydroxyl phenylacetic acid will be completely converted in 48h, 3g/L is 3,4-DHPA, conversion ratio 100%.
(Fig. 2)
Specific embodiment 2
The single carbon that conforms to the principle of simplicity source de novo formation 3,4-DHPA
Pass through the enzyme reported in sequence alignment (https: //blast.ncbi.nlm.nih.gov) analysis and document
Activity comparison, screening derive from the prephenate dehydrogenase TyrA of bacterium, fungi or protein engineering transformation, phosphoenolpyruvate
Synthase PpsA, transketolase TktA, 3- deoxidation-D-arabinose-heptonic acid -7- phosphate synthase AroG, aminopherase AT, ketone
Acid decarboxylase ARO10, phenylacetaldehyde dehydrogenase FeaB, 4-Hydroxyphenylacetate 3-monooxygenase HpaBC can be by glucose and glycerol point
It is not converted into the red moss ketone (E4P) of 4- phosphoric acid and phosphoenolpyruvate (PEP), is then branch by shikimic acid pathway catalysis
Acid (chorismate), Single-chip microcomputer, para hydroxybenzene acetaldehyde (4-HPAA), p-hydroxyphenylaceticacid (4-HPA), then
It is converted into 3,4-DHPA.Wherein the transformation of HpaBC includes F101A, S112G, A128N, E144T, P152Y, and TyrA is transform as
TyrAfbr, AroG transform AroG asfbr.Then aminopherase (AT) is obtained with PCR, keto acid decarboxylase (ARO10), phenylacetaldehyde
Dehydrogenase FeaB, 4-Hydroxyphenylacetate 3-monooxygenase (HpaBC) and the TyrA for enhancing shikimic acid pathwayfbr, PpsA, TktA and
AroGfbrThe genetic fragment of enzyme, later by target gene fragment be inserted into plasmid pZE12-luc (height copy) and pCS27 (in copy
Shellfish) on, obtain plasmid pZE-ARO10-FeaB-HpaBC, pZE-ARO10-FeaB, pCS-TPTA and pCS-TPTA-HpaBC.
It takes 2 μ L of the plasmid pZE-ARO10-FeaB-HpaBC built to mix with 2 μ L of pCS-TPTA, takes pZE-ARO10-
2 μ L of FeaB is mixed with 2 μ L of pCS-TPTA-HpaBC, and electricity is gone in the 100 μ L Escherichia coli for having been made into competence respectively,
After the completion of electricity turns, 700 μ L LB culture mediums is added, and mixture is transferred in 1.5mL centrifuge tube, recovers at 37 DEG C
30min.100 μ L bacterium solutions are taken to be coated onto containing ammonia benzyl mycin later, on the plate of kanamycins antibiotic, 37 DEG C are incubated overnight.Shape
At de novo formation 3, the bacterial strain BW (pZE-ARO10-FeaB-HpaBC, pCS-TPTA) of 4-DHPA, BW (pZE-ARO10-FeaB,
pCS-TPTA-HpaBC)。
At coli strain BW (pZE-ARO10-FeaB-HpaBC, pCS-TPTA), BW (pZE-ARO10-FeaB,
PCS-TPTA-HpaBC three parallel single colonies of picking on plate), be connected to 4mL has ammonia benzyl mycin, and kanamycins is anti-
Property liquid LB in, 37 DEG C of culture 12h, later respectively by the bacterium solution of 1mL (volume ratio 2%) be inoculated into 50mL with ammonia benzyl
1mM is added after then cultivating 3 hours in 37 DEG C, the shaking table of 200r/min in mycin, the M9 culture medium of kalamycin resistance
IPTG is induced.It is sampled every 12h, and measures the concentration of 3,4-DHPA with high performance liquid chromatography.Finally, discovery module
The yield ratio BW (pZE-ARO10- of bacterial strain BW (pZE-ARO10-FeaB, pCS-TPTA-HpaBC) 3,4-DHPA of optimization
FeaB-HpaBC, pCS-TPTA) high 600mg/L, up to 916 ± 48mg/L.(Fig. 3)
Specific embodiment 3
3,4-DHPA yield is improved by gene regulation strategy
Among the approach for producing 3,4-DHPA, intermediate phosphate enol pyruvic acid (PEP) will largely be converted into acetone
Sour (pyr), and enter tricarboxylic acid cycle (TCA cycle).Therefore on the basis of host strain BW25113, by host genome
Gene PYKA, PYKF or PYKA and PYKF of middle encoding pyruvate acid kinase are knocked out, and prevent PEP from being largely converted into acetone for effective
Sour (pyr) provides a large amount of precursors for the biosynthesis of 3,4-DHPA, decreases the generation of by-product.Pass through RED gene
Editing technique obtains bacterial strain Δ PYKA BW, Δ PykK BW and Δ PYKA PYKF BW.Next, respectively by plasmid pZE-
Electricity rotates into three kinds of engineered strains ARO10-FeaB and pCS-TPTA-HpaBC together, obtains bacterial strain Δ PYKA BW (pZE-
ARO10-FeaB, pCS-TPTA-HpaBC), Δ PykK BW (pZE-ARO10-FeaB, pCS-TPTA-HpaBC) and Δ PYKA
PYKF BW (pZE-ARO10-FeaB、pCS-TPTA-HpaBC)。
Three parallel single colonies that above-mentioned three kinds of bacterial strains are picked them separately on plate, be connected to 4mL has ammonia benzyl mycin,
In the liquid LB of kalamycin resistance, and it is transferred in M9 culture medium and ferments respectively after 37 DEG C of culture 12h.Exist respectively
12h, for 24 hours, 36h, 48h be sampled, and with high performance liquid chromatography measure 3,4-DHPA concentration.Finally, bacterial strain Δ PYKA
PYKF BW (pZE-ARO10-FeaB, pCS-TPTA-HpaBC) has reached the maximum output (Fig. 4) of 1856 ± 67mg/L.
Claims (4)
1. a kind of method of biosynthesis 3,4- dihydroxyphenyl acetic acid, it is characterised in that: under being 6-8 at 30-37 DEG C and pH, 4- hydroxyl
Base phenylacetic acid 3- monooxygenase HpaBC is catalyzed 3 to 60 hours, and catalysis 4- hydroxyl phenylacetic acid is generated 3,4- dihydroxyphenyl acetic acid.
2. according to the method described in claim 1, it is characterized by: screening is from bacterium, fungi or by protein engineering
The gene HpaBC of the coding 4-Hydroxyphenylacetate 3-monooxygenase of transformation.
3. the method as described in claim 1-2 any one, it is characterised in that: 3, the places of 4- dihydroxyphenyl acetic acid production ways
Main includes bacterium, fungi, plant cell or zooblast, also includes the bacterium being transformed, fungi, plant cell or animal are thin
Born of the same parents.
4. according to the method described in claim 1, it is characterized by: by the gene of encoding pyruvate acid kinase in host genome
PYKA, PYKF or PYKA and PYKF are knocked out, and improve 3,4- dihydroxyphenyl acetic acid yield.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811600449.6A CN109609560A (en) | 2018-12-26 | 2018-12-26 | Method for biosynthesizing 3,4-dihydroxyphenylacetic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811600449.6A CN109609560A (en) | 2018-12-26 | 2018-12-26 | Method for biosynthesizing 3,4-dihydroxyphenylacetic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109609560A true CN109609560A (en) | 2019-04-12 |
Family
ID=66011549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811600449.6A Pending CN109609560A (en) | 2018-12-26 | 2018-12-26 | Method for biosynthesizing 3,4-dihydroxyphenylacetic acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109609560A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110157746A (en) * | 2018-02-06 | 2019-08-23 | 赣南师范大学 | A method for microbial synthesis of plant auxin |
| CN114941000A (en) * | 2022-05-31 | 2022-08-26 | 南京合谷生命生物科技有限公司 | Gene mutant of key enzyme in biosynthetic pathway of protocatechuic acid ethyl ester and application of gene mutant |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100068775A1 (en) * | 2006-11-27 | 2010-03-18 | Jihane Achkar | Novel genes for the fermentative production of hydroxytyrosol |
| US20130130340A1 (en) * | 2011-11-07 | 2013-05-23 | Yajun Yan | Biosynthesis of caffeic acid and caffeic acid derivatives by recombinant microorganisms |
| CN105907804A (en) * | 2016-06-04 | 2016-08-31 | 北京化工大学 | Method for heterologous biosynthesis of tonquinol, caffeol and ferulenol |
| CN107586794A (en) * | 2017-11-01 | 2018-01-16 | 北京化工大学 | The method of heterologous metabolic pathway production tyrosol and hydroxytyrosol |
-
2018
- 2018-12-26 CN CN201811600449.6A patent/CN109609560A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100068775A1 (en) * | 2006-11-27 | 2010-03-18 | Jihane Achkar | Novel genes for the fermentative production of hydroxytyrosol |
| US20130130340A1 (en) * | 2011-11-07 | 2013-05-23 | Yajun Yan | Biosynthesis of caffeic acid and caffeic acid derivatives by recombinant microorganisms |
| CN105907804A (en) * | 2016-06-04 | 2016-08-31 | 北京化工大学 | Method for heterologous biosynthesis of tonquinol, caffeol and ferulenol |
| CN107586794A (en) * | 2017-11-01 | 2018-01-16 | 北京化工大学 | The method of heterologous metabolic pathway production tyrosol and hydroxytyrosol |
Non-Patent Citations (3)
| Title |
|---|
| ADELFO ESCALANTE，ET AL: "Metabolic engineering for the production of shikimic acid in an evolved Escherichia coli strain lacking the phosphoenolpyruvate: carbohydrate phosphotransferase system", 《MICROBIAL CELL FACTORIES》 * |
| NILS J. H. AVERESCH，ET AL: "Metabolic Engineering of the Shikimate Pathway for Production of Aromatics and Derived Compounds—Present and Future Strain Construction Strategies", 《FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY》 * |
| 程瑶等: "化合物代谢新途径构建及微生物糖代谢网络改造的研究进展", 《北京化工大学学报(自然科学版)》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110157746A (en) * | 2018-02-06 | 2019-08-23 | 赣南师范大学 | A method for microbial synthesis of plant auxin |
| CN110157746B (en) * | 2018-02-06 | 2022-12-13 | 赣南师范大学 | A method for microbial synthesis of plant auxin |
| CN114941000A (en) * | 2022-05-31 | 2022-08-26 | 南京合谷生命生物科技有限公司 | Gene mutant of key enzyme in biosynthetic pathway of protocatechuic acid ethyl ester and application of gene mutant |
| CN114941000B (en) * | 2022-05-31 | 2024-04-26 | 南京合谷生命生物科技有限公司 | Primary catechin ethyl ester biosynthesis pathway key enzyme gene mutant and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102453691B (en) | Escherichia coli engineering bacteria capable of realizing high yield of L-tryptophan | |
| Dong et al. | In situ carbon dioxide fixation in the process of natural astaxanthin production by a mixed culture of Haematococcus pluvialis and Phaffia rhodozyma | |
| CN104388330B (en) | A kind of method of L tryptophans fermentation strain and its fermenting and producing L tryptophans | |
| CN114717172B (en) | Escherichia coli for synthesizing L-valine and construction method and application thereof | |
| CN107586794A (en) | The method of heterologous metabolic pathway production tyrosol and hydroxytyrosol | |
| CN101705193B (en) | Astaxanthin-producing marine Rhodotorula YS-185 and its production method for astaxanthin | |
| Liu et al. | Improvement of astaxanthin production by a newly isolated Phaffia rhodozyma mutant with low‐energy ion beam implantation | |
| Yang et al. | Two-step production of gamma-aminobutyric acid from cassava powder using Corynebacterium glutamicum and Lactobacillus plantarum | |
| CN109971676B (en) | Breeding method and application of corynebacterium glutamicum capable of highly producing isoleucine | |
| CN109295113A (en) | A kind of method for producing hydroxytyrosol | |
| CN105543156A (en) | Recombinant strain and preparation method and application thereof | |
| Thanapimmetha et al. | Production of carotenoids and lipids by Rhodococcus opacus PD630 in batch and fed-batch culture | |
| CN102268385B (en) | Arthrobacter for fermentation production of cyclic adenosine monophosphate and application thereof | |
| CN106032538A (en) | Metabolic engineering bacteria and application thereof to production of vanillin by using various substrates | |
| CN109370967A (en) | A kind of engineering bacteria and its application in tyrosol production | |
| CN109609560A (en) | Method for biosynthesizing 3,4-dihydroxyphenylacetic acid | |
| CN106047740B (en) | A high-yielding strain of L-alanine | |
| Yang et al. | Accumulation of γ‐aminobutyric acid by E nterococcus avium 9184 in scallop solution in a two‐stage fermentation strategy | |
| CN103114069B (en) | Bacterium for fermenting L-tryptophan from mixed saccharum and fermentation method thereof | |
| CN115637276B (en) | Method for producing tetrahydropyrimidine by using halomonas strain | |
| CN112646760B (en) | Engineering bacterium for producing inositol and construction method and application thereof | |
| CN109576261A (en) | A kind of selection of the Corynebacterium glutamicum of high yield isoleucine and application | |
| CN102417892B (en) | Feeding lactobacillus johnsonii high-density fermentation medium and application thereof | |
| CN116179402A (en) | Carotenoid synthetic strain and application thereof | |
| CN101864389B (en) | Clostridium acetobutylicum strain and screening method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190412 |